Doctors use survival rates as a way of discussing one’s outlook (prognosis). A five-year survival rate is the percentage of patients who lived for at least five years after diagnosis of cancer. The uterine cancer survival rates also depend on the previous outcomes of large numbers of people who at one point happened to have cancer.
However, this can change depending on one’s general health, the grade of the cancer, how well one responds to treatment and the treatment doctors administered. However, these rates are estimates and only apply to first cases of cancer.
Relative uterine cancer survival rates are a more accurate way to estimate the effect of cancer on survival. Additionally, experts acquire survival rates by comparing patients with prostate cancer to the general population. Furthermore, the relative cancer survival rates express survivability regarding percentages. It is can also vary depending on the stage the cancer is currently at.
The summary steps used by SEER to break down statistics concerning the uterine cancer survival rates and the rates are: (1)
- Localized: The cancer is only in the uterus and relates to stage I.
- Regional: cancer has spread to nearby tissues or lymph nodes and is related to phase II and III.
- Distant: cancer has spread further and is related to stage IVA and IVB.
- Localized stage: The 5-year relative survival rate is about 63%
- Regional stage: The 5-year relative survival rate is about 36%
- Distant stage: The 5-year relative survival rate is about 14%
- Localized stage: The 5-year relative survival rate is about 70%
- Regional stage: The 5-year relative survival rate is about 43%
- Distant stage: The 5-year relative survival rate is about 23%
Endometrial Stromal Sarcoma(2)
- Localized stage: The 5-year relative survival rate is about 99%
- Regional stage: The 5-year relative survival rate is about 94%
- Distant stage: The 5-year relative survival rate is about 69%
Staging Of Uterine Cancer
In the analysis of cancer survival rates and prognosis, staging is the process of finding out how widespread the disease. Furthermore, surgeons use it to determine what type of treatment they will apply to their patient. Lastly, doctors perform it by examining the location and the type of the cancer tissue.
Staging is important for uterine cancer because it can determine different prognoses at the various stages and therefore doctors administer different treatments accordingly. It helps to determine one’s health condition to know if the cancer needs treatment or not.
Most physicians use FIGO (International Federation of Gynecology and Obstetrics) staging system when performing staging processes. It relies entirely on surgery results.
- Tumor: This refers to the extent of the primary tumor.
- Node: On the other hand, it the presence or absence of metastasis to nearby lymph nodes.
- Metastasis: Lastly, this describes the presence or absence of distant metastasis.
Stages Of Uterine Cancer
The T, N, M staging of uterine cancer include the following steps:
- Stage I: Cancer has not spread to the lymph nodes or nearby tissues. Furthermore, no single tumor has spread to the blood vessels and deeper uterine layers.
- Stage II: There is a single tumor that has grown deeper into the uterine. Though, cancer has not spread to nearby lymph nodes or distant sites.
- Stage III: Cancer has not spread to the nearby lymph node or distant sites. However, cancer has spread to the blood vessels and deep down in the uterine. The cancer has ulcerated the surrounding tissues and has thickened.
- Stage IV: Cancer has spread to other parts of the body. It has also spread to the nearby lymph nodes and distant sites. Lastly, it has spread beyond the original area of uterine.